Full Text
Budget Impact Analysis of Regorafenib in the Third-Line Treatment of Patients with Metastatic Colorectal Cancer

Abstract

Authors

S Zhu J Liu W Sun J Xuan

Back to Volume 21, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×